We are testing a modified T cell treatment for children with relapsed or hard-to-treat B-cell leukemia and lymphoma. The study aims to evaluate safety and effectiveness in helping these patients achieve remission.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition refers to a type of blood cancer where the body produces too many immature white blood cells (acute lymphoblastic leukemia) that do not function properly, and it can also involve aggressive lymphomas like diffuse large B cell lymphoma. It is termed 'relapsed' when the cancer returns after treatment and 'refractory' when it does not respond to treatment.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.